The General Electric-backed medical device developer has reached a first close of a $15m round that was led by Cormorant and backed by Lilly Asia Ventures.

US-based medical device developer NuVera Medical has completed the first closing of a $15m funding round that includes Lilly Asia Ventures, a corporate venturing subsidiary of pharmaceutical firm Eli Lilly. The tranche was led by hedge fund sponsor Cormorant Asset Management¬†and included investment firm Capital Partnership and unnamed existing backers. NuVera is developing ultrasound technology…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.